Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells.
暂无分享,去创建一个
[1] R. Champlin,et al. Allogeneic blood stem cell transplantation , 1997 .
[2] R. Storb,et al. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. , 1996, Blood.
[3] D. Munn,et al. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of antigen-specific peripheral lymphocyte deletion. , 1996, Journal of immunology.
[4] M. Mielcarek,et al. CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. , 1996, Blood.
[5] J. Jackson,et al. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. , 1996, Bone marrow transplantation.
[6] R. Storb,et al. Transplantation of allogeneic peripheral blood stem cells , 1995, Stem cells.
[7] R. Storb,et al. Transplantation of Allogeneic Peripheral Blood Stem Cells Mobilized by Recombinant Human Granulocyte Colony Stimulating Factor , 1996, Stem cells.
[8] J. Ferrara,et al. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. , 1995, Blood.
[9] C. Baldwin,et al. Monocytes control gamma/delta T-cell responses by a secreted product. , 1995, Immunology.
[10] S. Langabeer,et al. Accessory cells do not contribute to G‐CSF or IL‐6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation , 1995, British journal of haematology.
[11] R. Storb,et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor , 1995 .
[12] A. Deisseroth,et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts , 1995 .
[13] N. Schmitz,et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) , 1995, Blood.
[14] J. Gribben,et al. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. , 1994, Blood.
[15] H. Goldschmidt,et al. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] W. Bensinger,et al. Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. , 1994, Bone marrow transplantation.
[17] J. Radford,et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis , 1993 .
[18] L. Davis,et al. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. , 1993, Journal of immunology.
[19] L. Davis,et al. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. , 1993, Journal of immunology.
[20] R. Andreesen,et al. ALLOSTIMULATORY CELLS IN FRESH HUMAN BLOOD: HETEROGENEITY IN ANTIGEN‐PRESENTING CELL POPULATIONS , 1993, Transplantation.
[21] R. Andreesen,et al. ALLOSTIMULATORY CELLS IN FRESH HUMAN BLOOD: HETEROGENEITY IN ANTIGEN‐PRESENTING CELL POPULATIONS , 1993, Transplantation.
[22] N. Russell,et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation , 1993, The Lancet.
[23] N. Schmitz,et al. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter] , 1993 .
[24] C Anasetti,et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1 , 1993, The Journal of experimental medicine.
[25] J. Singer,et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. , 1993, Blood.
[26] J. Singer,et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. , 1993, Blood.
[27] J. Allison,et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.
[28] Y. I. Kim,et al. Induction of immunosuppressive activity by splenic macrophages in liver-grafted rats. , 1991, Transplantation proceedings.
[29] A. Kessinger. Autologous transplantation with peripheral blood stem cells: a review of clinical results. , 1990, Journal of clinical apheresis.
[30] B. Dupont,et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. , 1986, Blood.
[31] E. Clark,et al. Studies of T Cell Proliferation Induced by Monoclonal Antibodies of the Second International Workshop , 1986 .
[32] T. Juji,et al. Allogeneic suppressive effects of pregnancy sera on monocytes of responding cells in human mixed lymphocyte reactions. , 1985, The Journal of clinical investigation.
[33] L Davies,et al. Bone marrow transplant. , 1985, Nursing times.
[34] L Davies,et al. Bone marrow transplant. , 1985, Nursing times.
[35] J. Pryjma,et al. Isolation and functional characteristics of FcR+ and FcR- human monocyte subsets. , 1984, Journal of immunology.
[36] J. Twomey,et al. A comparison of the regulatory effects of human monocytes, pulmonary alveolar macrophages (PAMs) and spleen macrophages upon lymphocyte responses. , 1983, Clinical and experimental immunology.
[37] B. Veit. Immunoregulatory activity of culture-induced suppressor macrophages. , 1982, Cellular immunology.
[38] K. Sullivan,et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients , 1982 .
[39] J. Oppenheim,et al. Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. , 1980, Journal of immunology.
[40] R. van Furth,et al. Characteristics of human mononuclear phagocytes. , 1979, Blood.
[41] L. Rice,et al. Three suppressor systems in human blood that modulate lymphoproliferation. , 1979, Journal of immunology.
[42] L. Rice,et al. Three suppressor systems in human blood that modulate lymphoproliferation. , 1979, Journal of immunology.
[43] A. Weiss,et al. Macrophages suppress CTL generation in rat mixed leukocyte cultures. , 1977, Journal of immunology.
[44] A. Weiss,et al. Macrophages suppress CTL generation in rat mixed leukocyte cultures. , 1977, Journal of immunology.
[45] J. Twomey,et al. Suppression of lymphoproliferation by high concentrations of normal human mononuclear leukocytes. , 1977, Journal of immunology.
[46] W. Spector,et al. New Evidence for the Existence of Long Lived Macrophages , 1969, Nature.
[47] W. Spector,et al. New Evidence for the Existence of Long Lived Macrophages , 1969, Nature.
[48] A. Owens,et al. THE INDUCTION OF GRAFT VERSUS HOST DISEASE IN MICE TREATED WITH CYCLOPHOSPHAMIDE , 1968, The Journal of experimental medicine.
[49] A. Owens,et al. THE INDUCTION OF GRAFT VERSUS HOST DISEASE IN MICE TREATED WITH CYCLOPHOSPHAMIDE , 1968, The Journal of experimental medicine.
[50] L. Melstrom,et al. Malignancy. , 1938, California and western medicine.
[51] L. Melstrom,et al. Malignancy. , 1938, California and western medicine.